Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics

Bioconjugate Chemistry

Volumn 22, Issue 6, 2011, Pages 1056-1065

  Cohen, Jessica L ^a   Schubert, Stephanie ^a   Wich, Peter R ^a   Cui, Lina ^a   Cohen, Joel A ^a   Mynar, Justin L ^a   Fréchet, Jean M J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; DEXTRAN; LIPOSOMES;

ACID SENSITIVES; CATIONIC DEXTRAN; DELIVERY SYSTEMS; GENE KNOCK DOWN; IN-VITRO; LIPOFECTAMINE; MICROPARTICULATES; TRANSFECTION REAGENTS;

TOXICITY;

DEXTRAN; LIPOFECTAMINE; SMALL INTERFERING RNA; SPERMINE AC DEX; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED STUDY; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VITRO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; NANOENCAPSULATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 79959201542     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100542r     Document Type: Article

References (64)

1. Fougerolles, A., Vornlocher, H.-P., Maraganore, J., and Lieberman, J. (2007) Interfering with disease: A progress report on siRNA-based therapeutics Nat. Rev. Drug Discovery 6, 443-453 (Pubitemid 47064567)
2. Bumcrot, D., Manoharan, M., Koteliansky, V., and Sah, D. W. Y. (2006) RNAi therapeutics: A potential new class of pharmaceutical drugs Nat. Chem. Biol. 2, 711-719 (Pubitemid 44764213)
3. Kurreck, J. (2009) RNA interference: From basic research to therapeutic applications Angew. Chem., Int. Ed. 48, 1378-1398
4. Hammond, S. M., Caudy, A. A., and Hannon, G. J. (2001) Post-transcriptional gene silencing by double-stranded RNA Nat. Rev. Genet. 2, 110-119 (Pubitemid 33674002)
5. Tuschl, T. (2001) RNA interference and small interfering RNAs ChemBioChem 2, 239-245 (Pubitemid 33722551)
6. Bernstein, E., Caudy, A. A., Hammond, S. M., and Hannon, G. J. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference Nature 409, 363-366 (Pubitemid 32151243)
7. Rand, T. A., Ginalski, K., Grishin, N. V., and Wang, X. (2004) Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity Proc. Natl. Acad. Sci. U.S.A. 101, 14385-14389 (Pubitemid 39346758)
8. Ameres, S. L., Martinez, J., and Schroeder, R. (2007) Molecular basis for target RNA recognition and cleavage by human RISC Cell 130, 101-112 (Pubitemid 47031315)
9. Hutvágner, G. and Zamore, P. D. (2002) A microRNA in a multiple-turnover RNAi enzyme complex Science 297, 2056-2060
10. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009) Knocking down barriers: Advances in siRNA delivery Nat. Rev. Drug Discovery 8, 129-138
11. Fröhlich, T. and Wagner, E. (2010) Peptide- and polymer-based delivery of therapeutic RNA Soft Matter 6, 226-234
12. Pack, D. W., Hoffman, A. S., Pun, S., and Stayton, P. S. (2005) Design and development of polymers for gene delivery Nat. Rev. Drug Discovery 4, 581-593 (Pubitemid 40975711)
13. During, M. J. (1997) Adeno-associated virus as a gene delivery system Adv. Drug Delivery Rev. 27, 83-94 (Pubitemid 27301399)
14. Verma, I. M. and Somia, N. (1997) Gene therapy-Promises, problems, and prospects Nature 389, 239-242 (Pubitemid 27406627)
15. Schaffer, D. V., Koerber, J. T., and Lim, K. (2008) Molecular engineering of viral gene delivery vehicles Annu. Rev. Biomed. Eng. 10, 169-194
16. Mintzer, M. A. and Simanek, E. E. (2009) Nonviral vectors for gene delivery Chem. Rev. 109, 259-302
17. Thomas, C. E., Ehrhardt, A., and Kay, M. A. (2003) Progress and problems with the use of viral vectors for gene therapy Nat. Rev. Genet. 4, 346-358 (Pubitemid 36538359)
18. Zaiss, A. K. and Muruve, D. A. (2008) Immunity to adeno-associated virus vectors in animals and humans: A continued challenge Gene Ther. 15, 808-816 (Pubitemid 351712613)
19. Malone, R. W., Felgner, P. L., and Verma, I. M. (1989) Cationic liposome-mediated RNA transfection Proc. Natl. Acad. Sci. U.S.A. 86, 6077-6081 (Pubitemid 19210605)
20. Zimmerman, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., Judge, A. D., Lam, K., McClintock, K., Nechev, L. V., Palmer, L. R., Racie, T., Röhl, I., Seiffert, S., Shanmugam, S., Sood, V., Soutschek, J., Toudjarska, I., Wheat, A. J., Yaworski, E., Zedalis, W., Koteliansky, V., Manoharan, M., Vornlocher, H.-P., and MacLachlan, I. (2006) RNAi-mediated gene silencing in non-human primates Nature 441, 111-114
21. Neu, M., Fischer, D., and Kissel, T. (2005) Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives J. Gene Med. 7, 992-1009 (Pubitemid 41195062)
22. Zhang, S., Zhao, B., Jiang, H., Wang, B., and Ma, B. (2007) Cationic lipids and polymers mediated vectors for delivery of siRNA J. Controlled Release 123, 1-10 (Pubitemid 47444388)
23. Lares, M. R., Rossi, J. J., and Ouellet, D. L. (2010) RNAi and small interfering RNAs in human disease therapeutic applications Trends Biotechnol. 28, 570-579
24. Shim, M. S. and Kwon, Y. J. (2010) Efficient and targeted delivery of siRNA in vivo FEBS J. 277, 4814-4827
25. Little, S. R., Lynn, D. M., Ge, Q., Anderson, D. G., Puram, S. V., Chen, J., Eisen, H. N., and Langer, R. (2004) Poly-B-amino ester-containing microparticles enhance the activity of nonviral genetic vaccines Proc. Natl. Acad. Sci. U.S.A. 101, 9534-9539 (Pubitemid 38869271)
26. Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., and Saltzman, W. M. (2009) Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA Nat. Mater. 8, 526-533
27. Nguyen, J., Steele, T. W. J., Merkel, O., Reul, R., and Kissel, T. (2008) Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy J. Controlled Release 132, 243-251
28. Wang, C., Ge, Q., Ting, D., Nguyen, D., Shen, H.-R., Chen, J., Eisen, H. N., Heller, J., Langer, R., and Putnam, D. (2004) Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines Nat. Mater. 3, 190-196
29. Lee, S., Yang, S. C., Kao, C.-Y., Pierce, R. H., and Murthy, N. (2009) Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo Nucleic Acids Res. 37, e145
30. Little, S. R., Lynn, D. M., Puram, S. V., and Langer, R. (2005) Formulation and characterization of poly (B amino ester) microparticles for genetic vaccine delivery J. Controlled Release 107, 449-462 (Pubitemid 41393354)
31. Pack, D. W. (2004) Timing is everything Nat. Mater. 3, 133-134
32. Fu, K., Pack, D. W., Klibanov, A. M., and Langer, R. (2000) Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres Pharm. Res. 17, 100-106 (Pubitemid 30121107)
33. Walter, E., Moelling, K., Pavlovic, J., and Merkle, H. P. (1999) Microencapsulation of DNA using poly(DL-lactide-co-glycolide): Stability issues and release characteristics J. Controlled Release 61, 361-374 (Pubitemid 29413030)
34. Heinze, T., Liebert, T., Heublein, B., and Hornig, S. (2006) Functional polymers based on dextran Adv. Polym. Sci. 205, 199-291
35. Raemdonck, K., Naeye, B., Buyens, K., Vandenbroucke, R. E., Høgset, A., Demeester, J., and De Smedt, S. C. (2009) Biodegradable dextran nanogels for RNA interference: Focusing on endosomal escape and intracellular siRNA delivery Adv. Funct. Mater. 19, 1406-1415
36. Raemdonck, K., Naeye, B., Høgset, A., Demeester, J., and De Smedt, S. C. (2010) Prolonged gene silencing by combining siRNA nanogels and photochemical internalization J. Controlled Release 145, 281-288
37. Nagane, K., Jo, J.-I., and Tabata, Y. (2010) Promoted adipogenesis of rat mesenchymal stem cells by transfection of small interfering RNA complexed with a cationized dextran Tissue Eng., Part A 16, 21-31
38. Bachelder, E. M., Beaudette, T. T., Broaders, K. E., Dashe, J., and Fréchet, J. M. J. (2008) Acetal-derivatized dextran: An acid-responsive biodegradable material for therapeutic applications J. Am. Chem. Soc. 130, 10494-10495
39. Broaders, K. E., Cohen, J. A., Beaudette, T. T., Bachelder, E. M., and Fréchet, J. M. J. (2009) Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy Proc. Natl. Acad. Sci. U.S.A. 106, 5497-5502
40. Bachelder, E. M., Beaudette, T. T., Broaders, K. E., Fréchet, J. M. J., Albrecht, M. T., Mateczun, A. J., Ainslie, K. M., Pesce, J. T., and Keane-Myers, A. M. (2010) In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants Mol. Pharmaceutics 7, 826-835
41. Cohen, J. A., Beaudette, T. T., Cohen, J. L., Broaders, K. E., Bachelder, E. M., and Fréchet, J. M. J. (2010) Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells Adv. Mater. 22, 3593-3597
42. Rao, D. D., Vorhies, J. S., Senzer, N., and Nemunaitis, J. (2009) siRNA vs. shRNA: Similarities and differences Adv. Drug Delivery Rev. 61, 746-759
43. Gary, D. J., Puri, N., and Won, Y.-Y. (2007) Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery J. Controlled Release 121, 64-73 (Pubitemid 47126065)
44. Takahashi, Y., Nishikawa, M., and Takakura, Y. (2009) Nonviral vector-mediated RNA interference: Its gene silencing characteristics and important factors to achieve RNAi-based gene therapy Adv. Drug Delivery Rev. 61, 760-766
45. Murata, N., Takashima, Y., Toyoshima, K., Yamamoto, M., and Okada, H. (2008) Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice J. Controlled Release 126, 246-254
46. Vercauteren, R., Bruneel, D., Schacht, E., and Duncan, R. (1990) Effect of the chemical modification of dextran on the degradation by Dextranase J. Bioact. Compat. Polym. 5, 4-15 (Pubitemid 20150979)
47. Vercauteren, R., Schacht, E., and Duncan, R. (1992) Effect of the chemical modification of dextran on the degradation by rat liver lysosomal enzymes J. Bioact. Compat. Polym. 7, 346-357 (Pubitemid 23020212)
48. Crepon, B., Jozefonvicz, J., Chytry, V., ihová, B., and Kopeek, J. (1991) Enzymatic degradation and immunogenic properties of derivatized dextrans Biomaterials 12, 550-554
49. Gray, I. (1953) Metabolism of plasma expanders studied with carbon-14-labeled dextran Am. J. Physiol. 174, 462-466
50. de Belder, A. N. (1996) Medical Applications of Dextran and Its Derivatives. Polysaccharides in Medicinal Applications (Dumitriu, S., Ed.) pp 505-524, Chapter 16, Marcel Dekker, New York.
51. Rosenfeld, E. L. and Lukomskaya, I. S. (1957) The splitting of dextran and isomaltose by animal tissues Clin. Chim. Acta 2, 105-114
52. Rosenfeld, E. L. and Saienko, A. S. (1964) Metabolism in vivo of clinical dextran Clin. Chim. Acta 10, 223-228
53. Lynn, D. M. and Langer, R. (2000) Degradable poly(B-amino esters): Synthesis, characterization, and self-assembly with plasmid DNA J. Am. Chem. Soc. 122, 10761-10768
54. Azzam, T., Eliyahu, H., Shapira, L., Linial, M., Barenholz, Y., and Domb, A. J. (2002) Polysaccharide-oligoamine based conjugates for gene delivery J. Med. Chem. 45, 1817-1824 (Pubitemid 34415377)
55. Azzam, T., Eliyahu, H., Makovitzki, A., Linial, M., and Domb, A. J. (2004) Hydrophobized dextran-spermine conjugate as potential vector for in vitro gene transfection J. Controlled Release 96, 309-323 (Pubitemid 38481512)
56. Hosseinkhani, H., Azzam, T., Tabata, Y., and Domb, A. J. (2004) Dextran-spermine polycation: An efficient nonviral vector for in vitro and in vivo gene transfection Gene Ther. 11, 194-203 (Pubitemid 38159692)
57. Bernstein, A., Hurwitz, E., Maron, R., Arnon, R., Sela, M., and Wilchek, M. (1978) Higher antitumor efficacy of daunomycin linked to dextran J. Natl. Cancer Inst. 60, 379-383
58. Petros, R. A. and DeSimone, J. M. (2010) Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discovery 9, 615-627
59. Gautam, A., Densmore, C. L., Golunski, E., Xu, B., and Waldrep, J. C. (2001) Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI/DNA complexes Mol. Ther. 3, 551-556 (Pubitemid 32509849)
60. Jiang, H.-L., Xu, C.-X., Kim, Y.-K., Arote, R., Jere, D., Lim, H.-T., Cho, M.-H., and Cho, C.-S. (2009) The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethyleneimine/Akt1 shRNA complexes through the Akt signaling pathway Biomaterials 30, 5844-5852
61. Fuller, J. E. (2008) in Chemical Engineering, Massachusetts Institute of Technology, Cambridge.
62. Dalby, B., Cates, S., Harris, A., Ohki, E. C., Tilkins, M. L., Price, P. J., and Ciccarone, V. C. (2004) Advanced transfection with Lipofectamine 2000 reagent: Primary neurons, siRNA, and high-throughput applications Methods 33, 95-103 (Pubitemid 38569654)
63. Kongkaneramit, L., Sarisuta, N., Azad, N., Lu, Y., Iyer, A. K. V., Wang, L., and Rojanasakul, Y. (2008) Dependence of reactive oxygen species and FLICE inhibitory protein on Lipofectamine-induced apoptosis in human lung epithelial cells J. Pharmacol. Exp. Ther. 325, 969-977 (Pubitemid 351724344)
64. Beaudette, T. T., Cohen, J. A., Bachelder, E. M., Broaders, K. E., Cohen, J. L., Engleman, E. G., and Fréchet, J. M. J. (2009) Chemoselective ligation in the functionalization of polysaccharide-based particles J. Am. Chem. Soc. 131, 10360-10361